Back to Search Start Over

Hippo signalling in the liver: role in development, regeneration and disease.

Authors :
Russell JO
Camargo FD
Source :
Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2022 May; Vol. 19 (5), pp. 297-312. Date of Electronic Publication: 2022 Jan 21.
Publication Year :
2022

Abstract

The Hippo signalling pathway has emerged as a major player in many aspects of liver biology, such as development, cell fate determination, homeostatic function and regeneration from injury. The regulation of Hippo signalling is complex, with activation of the pathway by diverse upstream inputs including signals from cellular adhesion, mechanotransduction and crosstalk with other signalling pathways. Pathological activation of the downstream transcriptional co-activators yes-associated protein 1 (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ, encoded by WWTR1), which are negatively regulated by Hippo signalling, has been implicated in multiple aspects of chronic liver disease, such as the development of liver fibrosis and tumorigenesis. Thus, development of pharmacological inhibitors of YAP-TAZ signalling has been an area of great interest. In this Review, we summarize the diverse roles of Hippo signalling in liver biology and highlight areas where outstanding questions remain to be investigated. Greater understanding of the mechanisms of Hippo signalling in liver function should help facilitate the development of novel therapies for the treatment of liver disease.<br /> (© 2022. Springer Nature Limited.)

Details

Language :
English
ISSN :
1759-5053
Volume :
19
Issue :
5
Database :
MEDLINE
Journal :
Nature reviews. Gastroenterology & hepatology
Publication Type :
Academic Journal
Accession number :
35064256
Full Text :
https://doi.org/10.1038/s41575-021-00571-w